Form 4: CFO LeBlanc Acquires Dividend Equivalent Rights

Lemaitre Vascular CFO Dorian Paul LeBlanc acquired 2.5281 dividend equivalent rights tied to a restricted stock unit award.

Summary

• Dorian Paul LeBlanc, Chief Financial Officer of Lemaitre Vascular Inc. (LMAT), acquired 2.5281 Dividend Equivalent Rights (DERs) on September 4, 2025.
• These DERs accrued on a restricted stock unit (RSU) award that was granted on March 10, 2025.
• Each dividend equivalent right is the economic equivalent of one share of Lemaitre Vascular's common stock and vests proportionately with the underlying RSU award.
• Following this transaction, Mr. LeBlanc beneficially owns 8.4578 derivative securities.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary trading strategy.

Sentiment

Score: 6

Explanation: The acquisition of dividend equivalent rights by the CFO is a routine equity compensation event, indicating continued alignment of executive interests with shareholders. It is not a significant market-moving event but generally viewed as a neutral to slightly positive signal regarding insider commitment.

Positives

• The acquisition of Dividend Equivalent Rights indicates ongoing equity participation and alignment of management's interests with shareholders.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-planned, non-discretionary transaction that enhances transparency.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports a past insider transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity compensation activity. It does not provide information relevant to broader industry trends, competitive landscape, or market positioning for Lemaitre Vascular Inc.

Corporate Governance

Related Party Transactions

• The transaction involves the Chief Financial Officer and the company, which is a standard related-party transaction in the context of executive equity compensation.

Stakeholder Impact

• Shareholders: The transaction indicates continued alignment of the CFO's interests with shareholder value through equity compensation, potentially fostering confidence in management's long-term commitment.

Next Steps

• The acquired dividend equivalent rights will vest proportionately with the underlying restricted stock unit award.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction related to equity compensation. It does not provide new financial performance data, strategic shifts, or material events that would warrant a change in investment recommendation. The acquisition of dividend equivalent rights by the CFO is a standard part of executive compensation and generally indicates continued alignment of interests, but it is not a catalyst for a 'buy' or 'sell' decision. Therefore, a 'hold' recommendation is appropriate as this filing alone does not alter the fundamental investment thesis.

Keywords

Lemaitre Vascular, LMAT, Dorian Paul LeBlanc, Chief Financial Officer, CFO, Dividend Equivalent Rights, DERs, Restricted Stock Units, RSUs, Insider Transaction, Form 4, Equity Compensation, Rule 10b5-1